SCS Capital Management LLC Has $26.12 Million Holdings in HCA Healthcare, Inc. $HCA

SCS Capital Management LLC lifted its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 137.9% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 68,180 shares of the company’s stock after purchasing an additional 39,524 shares during the period. SCS Capital Management LLC’s holdings in HCA Healthcare were worth $26,120,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently modified their holdings of the company. Chung Wu Investment Group LLC bought a new position in HCA Healthcare during the second quarter worth about $27,000. Clearstead Trust LLC increased its holdings in shares of HCA Healthcare by 311.8% during the second quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock worth $27,000 after purchasing an additional 53 shares during the period. Ameriflex Group Inc. acquired a new stake in HCA Healthcare during the second quarter worth approximately $27,000. Saudi Central Bank acquired a new position in HCA Healthcare in the 1st quarter valued at $26,000. Finally, WPG Advisers LLC acquired a new position in HCA Healthcare in the first quarter valued at about $27,000. Institutional investors own 62.73% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on HCA shares. Barclays boosted their target price on shares of HCA Healthcare from $445.00 to $494.00 and gave the company an “overweight” rating in a research report on Monday, October 27th. Zacks Research downgraded HCA Healthcare from a “strong-buy” rating to a “hold” rating in a report on Thursday, November 27th. TD Cowen upped their price objective on HCA Healthcare from $380.00 to $490.00 and gave the stock a “buy” rating in a research report on Monday, October 27th. Bank of America boosted their target price on HCA Healthcare from $430.00 to $470.00 and gave the stock a “neutral” rating in a research note on Monday, October 27th. Finally, Mizuho upped their price objective on shares of HCA Healthcare from $475.00 to $505.00 and gave the stock an “outperform” rating in a research report on Monday, October 27th. Fourteen research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. According to MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and a consensus price target of $474.53.

HCA Healthcare Price Performance

NYSE:HCA opened at $487.71 on Friday. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $520.00. The firm’s 50 day simple moving average is $458.64 and its 200 day simple moving average is $409.37. The company has a market cap of $111.29 billion, a PE ratio of 18.85, a P/E/G ratio of 1.44 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, topping analysts’ consensus estimates of $5.64 by $1.32. The company had revenue of $19.16 billion for the quarter, compared to analyst estimates of $18.55 billion. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. HCA Healthcare’s revenue was up 9.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $4.90 earnings per share. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Equities research analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be issued a $0.72 dividend. The ex-dividend date is Monday, December 15th. This represents a $2.88 annualized dividend and a yield of 0.6%. HCA Healthcare’s dividend payout ratio is presently 11.13%.

Insider Buying and Selling

In other news, EVP Michael S. Cuffe sold 3,836 shares of the business’s stock in a transaction dated Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the transaction, the executive vice president directly owned 31,503 shares of the company’s stock, valued at $13,194,716.52. The trade was a 10.85% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Michael R. Mcalevey sold 3,892 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the completion of the sale, the executive vice president owned 3,487 shares of the company’s stock, valued at approximately $1,652,105.73. The trade was a 52.74% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 1.30% of the stock is currently owned by insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.